Fundamental dimension Equity attribute | ATECPeer $11.11▼-2.20% Cap $1.72BP/E -15.4x QuantScore60/100 | GMEDLeader $81.41▼-0.31% Cap $10.93BP/E 20.5x QuantScore75/100 | IARTPeer $11.91▼-3.37% Cap $926.3MP/E 71.0x QuantScore44/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
88/100 |
75/100 |
25/100 |
Valuation Multiples, PEG & DCF upside | 18/100 | 74/100 | 78/100 |
Health Piotroski, Altman Z, leverage & liquidity | 43/100 | 96/100 | 43/100 |
Growth Revenue / earnings growth & margins | 69/100 | 75/100 | 17/100 |
Sentiment Analyst ratings, targets & revisions | 81/100 | 58/100 | 57/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -15.4x | 20.5x | 71.0x |
Forward P/E (next FY) | 34.0x | 16.3x | 5.1x |
EV / EBITDA (TTM) | 163.6x | 11.1x | 11.4x |
Price / Sales | 2.1x | 3.5x | 0.6x |
Price / Free Cash Flow | 412.9x | 14.6x | 9.4x |
PEG ratio | -0.31 | 0.40 | 0.11 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 7 / 9 | 7 / 9 |
Altman Z-Score | -0.28 (Distress) | 10.85 (Safe) | 1.28 (Distress) |
Total debt / equity | -50.05 | 0.02 | 1.88 |
Quick ratio | 1.1x | 2.9x | 2.2x |
Interest coverage | -1.1x | — | 6.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +25.0% | +16.7% | +1.5% |
Net income growth YoY | +11.6% | +422.3% | -7337.7% |
Gross margin (TTM) | 66.1% | 68.5% | 52.5% |
Operating margin (FY) | -10.7% | 16.3% | 4.2% |
FCF margin (FY) | 0.4% | 20.0% | -2.8% |
5. Trailing price performancePrice change over period |
1M return | +12.0% | +9.6% | -25.0% |
3M return | +34.5% | +6.4% | -39.8% |
6M return | +1.9% | -14.2% | +12.7% |
Year to date | -47.2% | -6.8% | -4.1% |
1Y return | -31.0% | +30.7% | -26.1% |
3Y return | -13.3% | +65.2% | -68.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $12.29 +10.6% upside | $49.72 -38.9% premium | $26.27 +120.6% upside |
Wall Street consensus target | $16.22 +46.0% · range $12.00–$24.00 | $95.13 +16.9% · range $80.00–$117.00 | $16.80 +41.1% · range $13.00–$25.00 |
Consensus stance | 85% Buy10% Hold5% Sell | 72% Buy25% Hold3% Sell | 43% Buy43% Hold14% Sell |